Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer

Figure 4

This figure shows the relationship of SUV with breast cancer subtypes including ER+/HER2- (luminal-A) tumors, HER2-overexpressing tumors (HER2 subtype), and ER-/PR-/HER2- (triple-negative, including basal-like and normal breast types) tumors. Only tumors with diameter between 1.5 cm and 2.5 cm were examined. HER2- tumors and triple-negative tumors exhibit higher SUV levels of 5.0 (5.3 SD) and 5.0 (1.9 SD), respectively, compared to luminal-A tumors with SUV of 3.6 (2.7 SD) (p = 0.05 and 0.002, respectively).

Back to article page